These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 16272614

  • 1. [Nuclear Receptor PPARs and magnesium].
    Fujii H.
    Clin Calcium; 2005 Nov; 15(11):52-64. PubMed ID: 16272614
    [Abstract] [Full Text] [Related]

  • 2. [PPARs-mediated intracellular signal transduction].
    Fujii H.
    Nihon Rinsho; 2005 Apr; 63(4):565-71. PubMed ID: 15828221
    [Abstract] [Full Text] [Related]

  • 3. Peroxisome proliferator-activated receptors and inflammation.
    Moraes LA, Piqueras L, Bishop-Bailey D.
    Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
    [Abstract] [Full Text] [Related]

  • 4. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.
    Cimini A, Benedetti E, Cristiano L, Sebastiani P, D'Amico MA, D'Angelo B, Di Loreto S.
    Neuroscience; 2005 Jun; 130(2):325-37. PubMed ID: 15664689
    [Abstract] [Full Text] [Related]

  • 5. Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation.
    Bishop-Bailey D, Bystrom J.
    Pharmacol Ther; 2009 Nov; 124(2):141-50. PubMed ID: 19615407
    [Abstract] [Full Text] [Related]

  • 6. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
    Bocher V, Chinetti G, Fruchart JC, Staels B.
    J Soc Biol; 2002 Nov; 196(1):47-52. PubMed ID: 12134632
    [Abstract] [Full Text] [Related]

  • 7. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
    Giaginis C, Tsantili-Kakoulidou A, Theocharis S.
    Fundam Clin Pharmacol; 2007 Jun; 21(3):231-44. PubMed ID: 17521292
    [Abstract] [Full Text] [Related]

  • 8. Peroxisome proliferator-activated receptors and the metabolic syndrome.
    Bragt MC, Popeijus HE.
    Physiol Behav; 2008 May 23; 94(2):187-97. PubMed ID: 18191967
    [Abstract] [Full Text] [Related]

  • 9. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes.
    Blaschke F, Takata Y, Caglayan E, Law RE, Hsueh WA.
    Arterioscler Thromb Vasc Biol; 2006 Jan 23; 26(1):28-40. PubMed ID: 16239592
    [Abstract] [Full Text] [Related]

  • 10. PPAR receptor activation: Experimental studies on cardiac structure and function.
    Bishop-Bailey D.
    Curr Opin Investig Drugs; 2010 Mar 23; 11(3):283-8. PubMed ID: 20178041
    [Abstract] [Full Text] [Related]

  • 11. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.
    Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W.
    Prog Lipid Res; 2006 Mar 23; 45(2):120-59. PubMed ID: 16476485
    [Abstract] [Full Text] [Related]

  • 12. [PPAR and diabetes].
    Terauchi Y, Kadowaki T.
    Nihon Rinsho; 2005 Apr 23; 63(4):623-9. PubMed ID: 15828230
    [Abstract] [Full Text] [Related]

  • 13. PPAR and Pain.
    Maeda T, Kishioka S.
    Int Rev Neurobiol; 2009 Apr 23; 85():165-77. PubMed ID: 19607969
    [Abstract] [Full Text] [Related]

  • 14. Nuclear receptors of the peroxisome proliferator-activated receptor (PPAR) family in gestational diabetes: from animal models to clinical trials.
    Arck P, Toth B, Pestka A, Jeschke U.
    Biol Reprod; 2010 Aug 01; 83(2):168-76. PubMed ID: 20427759
    [Abstract] [Full Text] [Related]

  • 15. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
    Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, Grimaldi PA, Kadowaki T, Lazar MA, O'Rahilly S, Palmer CN, Plutzky J, Reddy JK, Spiegelman BM, Staels B, Wahli W.
    Pharmacol Rev; 2006 Dec 01; 58(4):726-41. PubMed ID: 17132851
    [Abstract] [Full Text] [Related]

  • 16. [PPARs target genes].
    Takada I, Kato S.
    Nihon Rinsho; 2005 Apr 01; 63(4):573-7. PubMed ID: 15828222
    [Abstract] [Full Text] [Related]

  • 17. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
    Gervois P, Fruchart JC, Staels B.
    Nat Clin Pract Endocrinol Metab; 2007 Feb 01; 3(2):145-56. PubMed ID: 17237841
    [Abstract] [Full Text] [Related]

  • 18. Nuclear receptors, transcription factors linking lipid metabolism and immunity: the case of peroxisome proliferator-activated receptor gamma.
    Varga T, Nagy L.
    Eur J Clin Invest; 2008 Oct 01; 38(10):695-707. PubMed ID: 18837794
    [Abstract] [Full Text] [Related]

  • 19. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets.
    Brown JD, Plutzky J.
    Circulation; 2007 Jan 30; 115(4):518-33. PubMed ID: 17261671
    [Abstract] [Full Text] [Related]

  • 20. Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology.
    Wray J, Bishop-Bailey D.
    Exp Physiol; 2008 Jan 30; 93(1):148-54. PubMed ID: 17872966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.